S Peter Kim

Affiliations

  • Director at Entrada Therapeutics Inc. (TRDA), 2025-06-18
  • Exe V-P & Pres, Mrl at Merck & Co. Inc. (MRK), 2013-02-27
  • Officer at Merck Sharp & Dohme Corp. (MRK), 2009-11-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TRDA $14.59 25,000 $364,672.50 117,412 2024-05-14 Filing
TRDA $14.68 25,000 $367,010.00 92,412 2024-05-13 Filing
TRDA $14.59 25,000 $364,672.50 92,412 2024-05-14 Filing
TRDA $14.25 2,200 $31,340.98 67,412 2024-05-09 Filing
TRDA $14.04 2,276 $31,964.60 65,212 2024-05-08 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MRK $45.50 420,000 $19,110,672.00 170,706 2012-11-05 Filing